GGrantIndex
← Search

CCSG - Administrative Supplement-CHE - 2021

$115,000P30FY2021CANIH

University Of Chicago, Chicago IL

Investigators

Linked publications, trials & patents

Paper 39661064Paper 39579248Paper 39438113Paper 39374047Paper 39270007Paper 39141403Paper 39114540Paper 39108474Paper 39071306Paper 39069988Paper 38883758Paper 38881356Paper 38849889Paper 38810242Paper 38771643Paper 38752924Paper 38735044Paper 38716867Paper 38691450Paper 38632339Paper 38561491Paper 38548994Paper 38536082Paper 38533736Paper 38496521Paper 38427437Paper 38421866Paper 38381713Paper 38294692Paper 38294689Paper 38293065Paper 38219706Paper 38213818Paper 38190286Paper 38186960Paper 38175791Paper 38155245Trial NCT02573363Trial NCT02573220Trial NCT02542202Trial NCT02540876Trial NCT02485535Trial NCT02420210Trial NCT02399371Trial NCT02389517Trial NCT02366819Trial NCT02333188Trial NCT02333162Trial NCT02275533Trial NCT02258659Trial NCT02213913Trial NCT02199665Trial NCT02122172Trial NCT02046421Trial NCT02012296Trial NCT01949740Trial NCT01861301Trial NCT01696955Trial NCT01576172Trial NCT01307618Trial NCT01281176Trial NCT01278615Trial NCT01267266Trial NCT01256385Trial NCT01208051Trial NCT01174264Trial NCT01122888Trial NCT01076543Trial NCT01064622Trial NCT00859937Trial NCT00720174Trial NCT00504153Trial NCT00436579Trial NCT00387335Trial NCT00381641Trial NCT00376688Trial NCT00369551Trial NCT00351975Trial NCT00303862Trial NCT00290472Trial NCT00265798Trial NCT00126542Trial NCT00095784Trial NCT00091026Trial NCT00087373Trial NCT00062075Trial NCT00058019Trial NCT00055913Trial NCT00039416Trial NCT00027703Trial NCT00023946Patent 7192711Patent 6870037Patent 6482934Patent 6387619Patent 6043216Patent 5916752Patent 5786344Patent 5698686Patent 5618917

Abstract

PROJECT SUMMARY/ABSTRACT The University of Chicago Medicine Comprehensive Cancer Center (UCCCC) is one of only two NCI- designated Cancer Centers in Illinois and is a major referral center for patients with cancer throughout the Midwest and the nation. The UCCCC catchment area includes five surrounding counties in Illinois (Cook, Will, DuPage, Lake) and one county in Northwest Indiana (Lake). Our catchment area has a sizable population of underserved minorities (19% African Americans, 22% Hispanic and 8% Asian Americans) and demonstrates a significant cancer burden, other related health care disparities in chronic disease burden (e.g., obesity, cardiovascular disease, diabetes, tobacco use), screening, and significant barriers due to adverse social determinants of health (e.g., poverty, insurance status, transportation). To address these gaps, the Community Health Educators (CHE) become critical connectors for the UCCCC to integrate underserved communities into research and identify better ways to bring evidence-based cancer control efforts to these communities. The UCCCC NON-CHE program is the only NON-CHE site in Illinois and one of the only programs conducting all three education initiatives. The CHE team is diverse and is able to provide education that is community specific but also bilingual (English/Spanish/Mandarin/Cantonese). The CHE team plans to expand partnerships to allow extended reach to our defined catchment area and the wider state efforts across Illinois using many of the web based /online adaptations the team has adapted due to COVID-19. Given the demographics and catchment data on disparities in cancer screening, incidence and mortality, the CHE team efforts will continue to focus on recruiting minority participation in all three NON-CHE initiatives: Clinical Trials (CT), Screen to Save (S2S), and HPV specifically in African American, Asian and Hispanic communities in the catchment area and Illinois. The options will include: 1) in person education sessions (when COVID-19 restrictions allow), 2) live webinar-based education sessions, and 3) online self-study education sessions using the Trainual platform will be created and hosted for independent study. All sessions will include appropriate consents and pre/post surveys. 150-200 participants with completed surveys for each initiative are anticipated as a minimum during the first 18 months of the grant period. The CHE program is fully integrated into the UCCCC COE programming and long-term strategic plan to ensure sustainable efforts. We expect that our CHEs will continue to be central to research and education/outreach efforts at the UCCCC and will continue to lead key COE initiatives. CHE will continue to develop sustainable partnerships and secure funding to continue community education in these key target initiatives areas as they align with disparities in our catchment area and with community and UCCCC mutually defined goals. Specific Aims Aim1: Expand community health educator (CHE) cancer control education and outreach effort Aim 2: Implement and evaluate NON-CHE education initiatives in the three target subjects (S2S, CT and HPV) across multiple platforms to maximize accessibility, reach and sustainability Aim 3: Promote education and participation in biobanking, screening and therapeutic clinical trials Aim 4: Accelerate colorectal cancer screening and HPV vaccination education and linkages to care Aim 5: Strengthen collaborations with key NCI-sponsored academic, research, community and regional partners Aim 6: Develop a comprehensive curriculum for community health workers (CHW) on cancer screening and clinical trial participation to promote a sustainable model for CHE-led community education efforts

View original record on NIH RePORTER →